Primer: signal transduction in rheumatic disease--a clinician's guide

Susan E Sweeney1, Gary S Firestein

  • 1Division of Rheumatology, Allergy and Immunology, University of California San Diego, Department of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0656, USA. ssweeney@ucsd.edu

Insights

Cellular signaling pathways, involving kinases, regulate gene expression for cell adaptation. Understanding these pathways in chronic inflammatory diseases could lead to new treatments targeting cytokine production.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • Cellular signaling pathways are crucial for responding to environmental stimuli.
  • Kinases drive downstream signaling cascades initiated by extracellular ligands binding to cell surface receptors.
  • Altered cellular signaling is implicated in various chronic inflammatory and autoimmune diseases.

Purpose of the Study:

  • To explore the role of intracellular signaling pathways in cellular responses to stimuli.
  • To identify key signaling cascades involved in inflammation and autoimmunity.
  • To highlight the therapeutic potential of understanding these pathways for treating inflammatory diseases.

Main Methods:

  • Review of established knowledge on cellular signaling mechanisms.
  • Identification of key enzymes (kinases) and transcription factors involved in signaling cascades.
  • Analysis of signaling pathways implicated in inflammatory and autoimmune conditions.

Main Results:

  • Signaling pathways involve ligand-receptor interactions, kinase activation, and transcription factor modulation of gene expression.
  • Specific pathways like MAPK, NF-κB, IRF, TLR, NLR, inflammasome, and PI3K are critical in inflammation.
  • These pathways ultimately enable cells to adapt to stimuli.

Conclusions:

  • Understanding intracellular signaling pathways is vital for comprehending inflammatory diseases.
  • Targeting these pathways offers potential for novel therapeutic strategies.
  • Orally bioavailable small molecules could be developed to regulate cytokine function and production for disease treatment.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...